CRISPR Therapeutics AG (CRSP) Non Operating Income (2015 - 2026)
CRISPR Therapeutics AG's Non Operating Income was $27.08 million in Q2 2026, up 22.7% from $22.07 million a year earlier and up 232.0% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Non Operating Income (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, CRISPR Therapeutics AG's Non Operating Income was $86.23 million through Jun 30, 2026, down 2.7% year-over-year; for FY2025, it came in at $86.61 million, down 16.6% from FY2024.
- Non Operating Income shows a five-year compound annual growth rate of 68.5% (FY2020 to FY2025).
- In earlier years, Non Operating Income was $103.9 million in FY2024 (+44.7%), $71.82 million in FY2023 (+216.9%), $22.66 million in FY2022 (+277.5%) and $6 million in FY2021 (-5.9%).
- The Q2 2026 figure marks the highest quarterly Non Operating Income since Q4 2024.
- Compared with a year earlier, Non Operating Income was higher in four of the last eight quarters, with an average decline of 2.9%.
- The best year-over-year quarter for Non Operating Income over five years was Q3 2021 (growth of 588.1%); the worst was Q1 2022 (a decline of 81.4%).
- Per Business Quant data, CRSP's Non Operating Income in the three quarters before Q2 2026 was $8.16 million (Q1 2026), $24.77 million (Q4 2025) and $26.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | CRISPR Therapeutics AG | 5.35 Bn | 5.35 Bn | - | 27.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.08 Mn |
| Mar 31, 2026 | 8.16 Mn |
| Dec 31, 2025 | 24.77 Mn |
| Sep 30, 2025 | 26.24 Mn |
| Jun 30, 2025 | 22.07 Mn |
| Mar 31, 2025 | 13.54 Mn |
| Dec 31, 2024 | 27.98 Mn |
| Sep 30, 2024 | 25.06 Mn |
| Jun 30, 2024 | 26.14 Mn |
| Mar 31, 2024 | 24.72 Mn |
| Dec 31, 2023 | 20.00 Mn |
| Sep 30, 2023 | 20.67 Mn |
| Jun 30, 2023 | 18.41 Mn |
| Mar 31, 2023 | 12.74 Mn |
| Dec 31, 2022 | 11.49 Mn |
| Sep 30, 2022 | 7.26 Mn |
| Jun 30, 2022 | 3.54 Mn |
| Mar 31, 2022 | 363,000.00 |
| Dec 31, 2021 | 2.20 Mn |
| Sep 30, 2021 | 1.10 Mn |
API Access
CRISPR Therapeutics AG Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();